Olivier SITBON

France

Research Interests

Explore related searches

Professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (19)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (10)

David Montani

Université de Paris Faculté de Santé

FRANCE

View details

Roger Thompson

Senior Lecturer

University of Sheffield

UNITED KINGDOM

View details

Bruno Fautrel

FRANCE

View details

Marc Humbert

Professeur des Universités Praticien Hospitalier

Université Paris-Saclay

FRANCE

View details

Christophe GUIGNABERT

Director of Research (DR1) - Full Professor of Molecular Biology & Physiology

INSERM

FRANCE

View details

Fabrice Antigny

INSERM

FRANCE

View details

Alice Huertas

INSERM

FRANCE

View details

Katarina Zeder

Medical University of Graz

AUSTRIA

View details

Etienne-Marie Jutant

Associate Professor

FRANCE

View details

Sandeep Sahay

Associate Professor

Houston Methodist Hospital

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Olivier SITBON

Research Interests

Explore related searches

Contact this professor

Articles (19)

Clustering Patients with Pulmonary Hypertension Using the Plasma Proteome

Correspondence on: Pulmonary arterial hypertension in adults with Still’s disease: another pulmonary manifestation associated with HLA-DRB1*15–reply

Response to correspondence on: Pulmonary arterial hypertension in adults with Still's disease: another pulmonary manifestation associated with HLA-DRB1*15

ERS Congress 2024: highlights from the Pulmonary Vascular Diseases Assembly

Seralutinib for the Treatment of Pulmonary Arterial Hypertension in Adults: TORREY Open-Label Extension Study

Drugs targeting novel pathways in pulmonary arterial hypertension

Diuretic adherence in patients with precapillary pulmonary hypertension: insights from the PHARE study

The Activin Pathway in Chronic Thromboembolic Pulmonary Hypertension: A Potential Biomarker for Residual Pulmonary Hypertension After Endarterectomy

Safety and Efficacy of upfront triple therapy including parenteral treprostinil compared to double oral therapy in PAH (TripleTRE): study protocol for a randomized trial

Risk stratification in Eisenmenger syndrome

Pulmonary arterial hypertension

Diagnosis and management of pulmonary veno-occlusive disease

New trends in pulmonary hypertension

The Influence of Methods for Cardiac Output Determination on the Diagnosis of Precapillary Pulmonary Hypertension: A Mathematical Model

Erythrocytes are altered in pulmonary arterial hypertension

To be or not to be… treated with initial combination therapy, that is the (PAH) question

ERS statement on chronic thromboembolic pulmonary hypertension

Sequential combination therapy with parenteral prostacyclin in BMPR2 mutations carriers

Sex and gender in pulmonary arterial hypertension

Collaborators (10)

David Montani

Roger Thompson

Bruno Fautrel

Marc Humbert

Christophe GUIGNABERT

Fabrice Antigny

Alice Huertas

Katarina Zeder

Etienne-Marie Jutant

Sandeep Sahay

Make your next move.